Understanding how migraines become chronic and how to reverse that process
Official title: Mechanisms of migraine chronification and reversal
Funded at Washington University · NIH-11071989 · Data updated 2026-11-12
This study is looking at how certain immune cells might help improve chronic migraines, using a mouse model to see if a treatment called low-dose interleukin-2 can help balance the immune system and reduce migraine symptoms for people who suffer from them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $428,510 |
| NIH project number | 5R01NS128080-03 |
| Project ID | NIH-11071989 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from chronic migraines who may have immune system imbalances.
✕Less likely to help
Patients with acute migraines or those who do not have any immune system involvement in their migraine condition may not benefit from this research.
What this research studies
This research investigates the role of specific immune cells, particularly CD3+ T lymphocytes and regulatory T cells, in the development and potential reversal of chronic migraines. By using a mouse model that mimics chronic migraine conditions, the study examines how these immune cells behave and how treatments like low-dose interleukin-2 can restore balance in the immune system. The goal is to uncover new therapeutic strategies that could alleviate the debilitating effects of chronic migraines for patients.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively reverse chronic migraines and improve patients' quality of life.
How similar studies have gone: Previous research has shown promise in using immune modulation to treat chronic conditions, suggesting that this approach may yield beneficial results.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Cao, Yuqing — Washington University
- Study coordinator: Cao, Yuqing
Related research
Other NIH-funded projects on the same topics.
-
Oxytocin as a potential migraine fighter for people with aura
A scientist-led study at a major hospital tests whether the brain chemical oxytocin can help stop or prevent migraine attacks that involve aura.
-
Meningeal pain and migraine brain hyperexcitability in people
A short study in adults with migraine to understand how pain signals from the brain coverings might make the visual cortex more excitable and trigger migraines.
-
Light exposure and sleep in teens with migraine
Teens with migraine and light sensitivity will wear sensors to track daily light and sleep, helping researchers understand how light exposure affects symptoms and nighttime rest.
-
Understanding migraine and eye pain: how light and nerves cause discomfort in migraine and dry eye
A research project is studying why eye pain and sensitivity to light happen in people with migraine and dry eye, and how surgery to correct vision may contribute to these symptoms.
-
Mi-Helper: a drug-free air-based device to relieve migraine pain
A new, drug-free device uses a gentle stream of dry air to calm migraine symptoms, aimed at people visiting emergency departments.
-
Molecular basis for S1PR1 blockers in migraine and TMD pain
A basic science project to explore how blocking S1PR1 could help people who have both migraine and temporomandibular disorders by studying pain pathways in animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.